Evidence map›Paper›PMID 27697757›Full record

ArticleAntimicrobial agents and chemotherapy2016

Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae.

Yun Zhang, Kechun Liu, Hozeifa M Hassan, Hongli Guo, Pingping Ding, Liwen Han, Qiuxia He, Weiyun Chen, Chung-Der Hsiao, Luyong Zhang and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Hypoglycemic Activity of Aqueous Extract of Latex fromPharmaceuticals (Basel, Switzerland) · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Toxicity Reduction ofMolecules (Basel, Switzerland) · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Yun ZhangBiology Institute of Shandong Academy of Sciences, Jinan, People's Republic of China.
Kechun LiuBiology Institute of Shandong Academy of Sciences, Jinan, People's Republic of China.
Hozeifa M HassanJiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, People's Republic of China.
Hongli GuoJiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, People's Republic of China.
Pingping DingJiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, People's Republic of China.
Liwen HanBiology Institute of Shandong Academy of Sciences, Jinan, People's Republic of China.
Qiuxia HeBiology Institute of Shandong Academy of Sciences, Jinan, People's Republic of China.
Weiyun ChenBiology Institute of Shandong Academy of Sciences, Jinan, People's Republic of China.
Chung-Der HsiaoDepartment of Bioscience Technology, Chung Yuan Christian University, Chung-Li, Taiwan.
Luyong ZhangJiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, People's Republic of China.
Zhenzhou JiangJiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, People's Republic of China beaglejiang@cpu.edu.cn.
China Pharmaceutical University · CNShandong Academy of Sciences · CNBiology Institute of Shandong Academy of Sciences · CNChung Yuan Christian University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyrazinamide (PZA) is an essential antitubercular drug, but little is still known about its hepatotoxicity potential. This study examined the effects of PZA exposure on zebrafish (Danio rerio) larvae and the mechanisms underlying its hepatotoxicity. A transgenic line of zebrafish larvae that expressed enhanced green fluorescent protein (EGFP) in the liver was incubated with 1, 2.5, and 5 mM PZA from 72 h postfertilization (hpf). Different endpoints such as mortality, morphology changes in the size and shape of the liver, histological changes, transaminase analysis and apoptosis, markers of oxidative and genetic damage, as well as the expression of certain genes were selected to evaluate PZA-induced hepatotoxicity. Our results confirm the manner of PZA dose-dependent hepatotoxicity. PZA was found to induce marked injury in zebrafish larvae, such as liver atrophy, elevations of transaminase levels, oxidative stress, and hepatocyte apoptosis. To further understand the mechanism behind PZA-induced hepatotoxicity, changes in gene expression levels in zebrafish larvae exposed to PZA for 72 h postexposure (hpe) were determined. The results of this study demonstrated that PZA decreased the expression levels of liver fatty acid binding protein (L-FABP) and its target gene, peroxisome proliferator-activated receptor α (PPAR-α), and provoked more severe oxidative stress and hepatitis via the upregulation of inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and transforming growth factor β (TGF-β). These findings suggest that L-FABP-mediated PPAR-α downregulation appears to be a hepatotoxic response resulting from zebrafish larva liver cell apoptosis, and L-FABP can be used as a biomarker for the early detection of PZA-induced liver damage in zebrafish larvae.

Indexed as

AnimalsAnimals, Genetically ModifiedAntitubercular AgentsApoptosisFatty Acid-Binding ProteinsGreen Fluorescent ProteinsHepatitisInflammationLarvaLiverOxidative StressPPAR alphaPyrazinamideReactive Oxygen SpeciesTransaminasesTransforming Growth Factor betaAntitubercular Agentsenhanced green fluorescent proteinFatty Acid-Binding ProteinsGreen Fluorescent ProteinsPPAR alphaPyrazinamideReactive Oxygen SpeciesTransaminasesTransforming Growth Factor betaTumor Necrosis Factor-alpha

Identifiers

PMID27697757
PMCPMC5119016
OpenAlexW2527961982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.